ARCHIVES

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 42 | November 1, 1991

Download PDF Visit The Full Archive

Related Articles

Two View Mammography Said Less Costly Than One In Screening

April 25, 1986

NCI Has No Intention Of “Dismembering” Groups, Official Says

June 12, 1998

Still Misperceptions On Hill About CRADA Between NCI, BMS

March 13, 1992

Adjuvant Chemotherapy Unneeded In Children with Low-Risk Disease

March 29, 2013

Professional Society Growth Obvious At Spring Meetings; AACR Looking To Broaden Its Base

June 5, 1987

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

July 6, 1990